In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 31st, 2008 | 31 | Yes |
Popular Name: Buclizine Buclizine
Find On: PubMed — Wikipedia — Google
CAS Numbers: 129-74-8 , 82-95-1 , [129-74-8]
1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine dihydrochloride
1-(4-(tert-Butyl)benzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazinedihydrochloride
1-(4-Tert-butylbenzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine
1-(4-tert-butylbenzyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine; 129-74-8; nsc25141
1-(4-tert-Butylbenzyl)-4-[(4-chlorophenyl)(phenyl)methyl]piperazine
1-(p-tert-Butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine
1-(p-tert-Butylbenzyl)-4-(4-chloro-alpha-phenylbenzyl)piperazine; Buclizine
1-[(4-chlorophenyl)(phenyl)methyl]-4-{[4-(1,1-dimethylethyl)phenyl]methyl}piperazine
1-[(4-tert-butylphenyl)methyl]-4-[(4-chlorophenyl)-phenylmethyl]piperazine
129-74-8; Buclizine hydrochloride (USAN); D02089; Vibazine (TN)
4-23-00-00082 (Beilstein Handbook Reference)
82-95-1; Buclina (TN); Buclizine (INN); D07547
Buclizina [INN-Spanish];Buclizinum [INN-Latin]
buclizina; buclizine; buclizinum
Buclizine Hydrochloride (*dihydrochloride*)
INN); Buclizine Hydrochloride (FDA
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)-
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((4-(1,1-dimethylethyl)phenyl)methyl)- (9CI)
PIPERAZINE, 1-(p-tert-BUTYLBENZYL)-4-(p-CHLORO-alpha-PHENYLBENZYL)-
Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[[4-(1,1-dimethylethyl)phenyl]methyl]-
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 7.19 | 16.42 | -39.97 | 1 | 2 | 1 | 8 | 434.047 | 6 | ↓ |
Mid Mid (pH 6-8) | 7.19 | 14.1 | -2.83 | 0 | 2 | 0 | 6 | 433.039 | 6 | ↓ |
Mid Mid (pH 6-8) | 7.19 | 15.9 | -37.54 | 1 | 2 | 1 | 8 | 434.047 | 6 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 2.46e-04 g/l | DrugBank-approved |
Indications | antihistamine | KeyOrganics Bioactives |
Patent Database Links | EP1832287; US2006040900; US2007265234; WO2005099702; WO2007109523 | ChEBI |
Target | Histamine Recepto | Selleck Chemicals |